In a safety-net hospital lacking allergy/immunology services, most patients with urticaria do not receive ...
Individuals diagnosed with chronic spontaneous urticaria (CSU) are at a moderately increased risk of multiple cardiovascular ...
Alys Pharmaceuticals has announced the dosing of the first subject in its phase 1/1b trial of ALY-301, a first-in-class mast ...
Q32025 net revenue of $26.1 million, driven by MIPLYFFA® net revenue of $22.4 millionCompany to host conference call and ...
Differentiated profile of ALY-301 designed to enable chronic dosing in mast cell dependent diseases while avoiding the safety limitations of conventional c-Kit inhibitors -- Multicenter Phase 1/1b ...
Breast cancer is commonly portrayed as challenging yet curable: A lump is discovered, then through some combination of ...
Daniel Owen, 47, originally from Idaho Falls, Idaho, and his son Cooper, 15, died following the attack at Green Jungle Park ...
Mad honey,” or “deli bal” as it’s known in Turkey, is a rare and potentially dangerous delicacy with psychoactive properties.
A once-rare meat allergy caused by tick bites is dramatically increasing across the United States, researchers say.
A mysterious red meat allergy stalks meat-loving Arkansans, but an alternative protein movement is sprouting up to offer the ...
New evidence suggests that introducing common sources of food allergies in the first year of life is associated with reductions in new cases in children. But prevention is only part of the story.
The immune drugmaker is the second biotech, along with MapLight Therapeutics, to recently use a workaround in U.S. securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback